Education
About Us
Working with TipRanks
Follow Us
Hologic (HOLX)
NASDAQ:HOLX
HOLX Stock Chart & Stats
$74.91
$0.05(0.07%)
At close: 4:00 PM EST
$74.91
$0.05(0.07%)
Day’s Range― - ―
52-Week Range$51.90 - $75.34
Previous CloseN/A
Volume386.02K
Average Volume (3M)3.03M
Market Cap
$16.72B
Enterprise Value$15.37B
Total Cash (Recent Filing)$1.88B
Total Debt (Recent Filing)$2.52B
Price to Earnings (P/E)30.2
Beta-0.02
Next Earnings
Feb 04, 2026EPS Estimate
1.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.13
Shares Outstanding223,048,020
10 Day Avg. Volume3,590,714
30 Day Avg. Volume3,026,137
Financial Highlights & Ratios
PEG Ratio-1.06
Price to Book (P/B)0.00
Price to Sales (P/S)3.71
P/FCF Ratio15.23
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue3.81
Enterprise Value/Gross Profit7.36
Enterprise Value/Ebitda14.09
Forecast
1Y Price Target
$77.56Price Target Upside3.54% Upside
Rating ConsensusHold
Number of Analyst Covering12
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Acquisition PremiumThe acquisition deal represents a 46% premium to HOLX's closing price prior to media reports about a possible transaction.
Mammography Market LeadershipHOLX is the leader in the mammography market and plans to launch its next-generation mammography system, Envision.
Revenue GrowthHologic's organic ex-COVID sales growth improved to 5.4% Y/Y in F4Q25 from (1.7%) Y/Y in F3Q25.
Bears Say
Acquisition RisksRisks include the take-private transaction being delayed or not closing, and slower-than-expected growth in Breast Health.
Market Share ConcernsAn acquisition by another med tech company is possible but less likely given potential antitrust issues due to HOLX's very high mammography market share in the US and its slower revenue growth.
Share DowngradeAnalysts are downgrading shares to EW-Vol. (from OW-Vol.) and adjusting the price target to $76 (from $78).
Hologic News
HOLX FAQ
What was Hologic’s price range in the past 12 months?
Hologic lowest stock price was $51.90 and its highest was $75.34 in the past 12 months.
What is Hologic’s market cap?
Hologic’s market cap is $16.72B.
When is Hologic’s upcoming earnings report date?
Hologic’s upcoming earnings report date is Feb 04, 2026 which is in 43 days.
How were Hologic’s earnings last quarter?
Hologic released its earnings results on Oct 21, 2025. The company reported $1.13 earnings per share for the quarter, beating the consensus estimate of $1.098 by $0.032.
Is Hologic overvalued?
According to Wall Street analysts Hologic’s price is currently Undervalued.
Does Hologic pay dividends?
Hologic does not currently pay dividends.
What is Hologic’s EPS estimate?
Hologic’s EPS estimate is 1.09.
How many shares outstanding does Hologic have?
Hologic has 223,048,020 shares outstanding.
What happened to Hologic’s price movement after its last earnings report?
Hologic reported an EPS of $1.13 in its last earnings report, beating expectations of $1.098. Following the earnings report the stock price went down -0.068%.
Which hedge fund is a major shareholder of Hologic?
Currently, no hedge funds are holding shares in HOLX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hologic Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$77.56 (3.54% Upside)
$77.56 (3.54% Upside)
Blogger Sentiment
Bullish
HOLX Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 133.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.7%
Last 30 Days ▲ 7.8%
Last 30 Days ▲ 7.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.54%
12-Months-Change
Fundamentals
Return on Equity
11.12%
Trailing 12-Months
Asset Growth
-1.54%
Trailing 12-Months
Company Description
Hologic
Hologic, Inc. is a global medical technology company primarily focused on women's health. Founded in 1985 and headquartered in Marlborough, Massachusetts, Hologic operates in several sectors, including diagnostics, medical imaging, and surgical products. The company's core offerings include innovative solutions for breast health, gynecological health, and skeletal health, with notable products such as mammography systems, molecular diagnostic tests, and surgical instruments.
HOLX Company Deck
HOLX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with strong financial performance and promising developments in the Breast Health and Diagnostics segments. Despite some challenges in specific markets and product lines, the company's strategic initiatives and successful product launches indicate a solid path toward growth.View all HOLX earnings summariesHOLX Revenue Breakdown
63.84% Disposables
15.57% Capital equipment, components and software
20.13% Service
0.46% Other
HOLX Stock 12 Month Forecast
Average Price Target
$77.56
▲(3.54% Upside)
Technical Analysis
Baxter International
―
Becton Dickinson
―
Intuitive Surgical
―
Resmed
―
West Pharmaceutical Services
―
Ownership Overview
1.43% Insiders
30.47% Mutual Funds
21.67% Other Institutional Investors
19.27% Public Companies and
Individual Investors